TruthArchive.ai - Related Video Feed

The speaker asks if the Pfizer COVID vaccine was tested for its ability to stop virus transmission before being released. They request a clear yes or no answer and the data to be shared with the committee. The response states that they did not have prior knowledge of stopping transmission before the vaccine entered the market and had to rely on scientific research. Another speaker expresses outrage, claiming that people were pressured to get vaccinated based on the false belief that it would protect others.

Speaker 0 states that one of their three children experienced health issues, including heart inflammation, after receiving the vaccine and subsequently lost their job for refusing further vaccination. This adverse reaction is officially registered. The speaker recounts a doctor advising their son against further vaccination outside a hospital setting, but later denying having said so. Speaker 1 says there is a good system for reporting side effects in New Zealand and finds no clear evidence of suppression of medical side effects of the Pfizer vaccine. Speaker 0 questions why the vaccine is still in use given the side effects. Speaker 1 responds that society decided to tolerate a certain number of adverse effects for the greater good, characterizing the speaker's family member's reaction as "taking one for the team."

The speaker asked if the Pfizer COVID vaccine was tested for stopping virus transmission before it was released. They wanted a clear yes or no answer and requested the data to be shared with the committee. In response, it was stated that no, they did not have knowledge about stopping transmission before the vaccine entered the market. They had to act quickly.

The discussion revolves around the efficacy and safety of COVID-19 vaccines, particularly in relation to transmission, myocarditis rates, and the influence of pharmaceutical companies. The speakers debate whether vaccines reduce transmission and the risks associated with myocarditis. They also question the motives of pharmaceutical companies and their impact on public health. Ultimately, they express differing views on the role of vaccines in preventing illness and the influence of pharmaceutical companies. Translation: The conversation focuses on COVID-19 vaccine effectiveness, safety, transmission, and myocarditis risks, as well as the pharmaceutical industry's influence on public health. Speakers debate vaccine impact on transmission and myocarditis rates, and discuss pharmaceutical companies' motives and health outcomes. They share conflicting opinions on vaccines' ability to prevent illness and the pharmaceutical industry's role.

Speaker 0 asks if the vaccine prevented people from getting COVID. Speaker 1 believes it lessened symptom severity and reduced emergency room visits, a view supposedly held by 90% of objective experts. Speaker 0 regrets getting vaccinated, fearing he would miss his son's birth. He got COVID a couple of weeks after vaccination and received conflicting test results, questioning the competence of the testers.

Speaker 0 is hesitant about getting the vaccine, but Speaker 2 explains that getting vaccinated protects others. Speaker 3 is skeptical due to the quick vaccine development. Speaker 1 emphasizes the importance of vaccination to stop the virus spread. Speaker 3 believes there is fear-mongering around the pandemic.

Speaker 1 expresses skepticism about the COVID-19 vaccine due to lack of clarity and the speed at which it was developed. Speaker 2 counters by explaining that 20 years of scientific research contributed to its creation. Speaker 0, who is vaccinated, argues that if more people refuse the vaccine, the virus will continue to spread. Speaker 1 questions the accuracy of COVID-19 death numbers and suggests ulterior motives behind vaccine incentives. Speaker 0 emphasizes the importance of protecting health and the city. Speaker 1 accuses the pandemic of being fear-driven.

Speaker 0 asks if Speaker 1 is vaccinated, to which Speaker 1 responds that they are not. Speaker 1 explains that they advised their family and loved ones against getting vaccinated because they believed the vaccine was experimental, not tested on humans, and had concerns about the company behind it. They also mention that most vaccines typically take several years to gather safety data before approval. Speaker 1 expresses their intuition that Operation Warp Speed, the vaccine development initiative, seemed rushed and lacking in safety protocols. However, Speaker 1 did not anticipate the widespread propaganda campaign promoting vaccination, and they were horrified to see everyone around them rushing to get vaccinated without proper testing.

The speaker asks if there is a higher incidence of myocarditis among adolescent males aged 16 to 24 after taking the vaccine. The other speaker responds by saying that the data from the CDC shows that there is actually less myocarditis in people who get the vaccine compared to those who get COVID. The first speaker disagrees and presents six peer-reviewed papers that contradict this claim. They also mention speaking with the president who privately acknowledged the increased risk of myocarditis. The conversation then shifts to discussing the rationality of mandating three vaccines for adolescent boys and the timing of myocarditis after the second dose. The first speaker criticizes the CDC's recommendation to vaccinate individuals who have recovered from COVID and experienced myocarditis. They argue that many countries do not offer the vaccine to children unless they are at risk for severe disease. The first speaker concludes by stating that the risk and benefits of vaccination need to be weighed, and that parents are unlikely to comply with mandatory vaccination for their children.

The speaker asks if there is a higher incidence of myocarditis among boys aged 16 to 24 after taking the vaccine. The other speaker responds that the data from the CDC actually show that there is less risk of myocarditis for those who get the vaccine compared to those who get COVID infection. The first speaker clarifies if they are saying that males in the 16 to 24 age group who take the vaccine have a lower risk of myocarditis than those who contract the disease. The second speaker confirms this.

Speaker 0 asks Speaker 1 if they got the vaccine, to which Speaker 1 confirms that they did. Speaker 1 explains that they felt pressured by their friends to get the vaccine and later discovered some concerning particles in their blood work. They underwent a plasma treatment to remove heavy metals from their blood. Speaker 1 believes that there may have been an overreaction to the pandemic and suggests that there may have been ulterior motives at play. Speaker 0 agrees and mentions that they kept their gym open during that time. They both express skepticism and question the consistency of the actions taken during the pandemic.

Pfizer was asked if they tested whether their COVID-19 vaccine could reduce or stop the transmission of the virus before its approval. The Pfizer representative stated that the primary purpose of the vaccine was to protect the person who received it and prevent illness, severe disease, and hospitalizations. The senator then referred to a statement made by Pfizer's CEO on December 3, 2020, where he mentioned uncertainty about the vaccine's ability to reduce transmission. The Pfizer representative reiterated that their clinical programs were designed to demonstrate the vaccine's safety and effectiveness in preventing infections. Due to time constraints, the senator moved on without a definitive answer.

Speaker 0 confronts a pharmacist about their son's hospitalization due to myocarditis after receiving a COVID jab. Speaker 0 is upset that his wife was not informed about this potential side effect. Speaker 1 explains that they may not disclose the side effect to avoid scaring parents away from vaccinating their children. Speaker 0 expresses disbelief and insists that parents should be given accurate information to make informed decisions.

Speaker 0 acknowledges reports of myocarditis and pericarditis associated with the Pfizer vaccine but seems unsure about the mechanism behind it. Speaker 1 asks if the vaccine was tested for its ability to stop virus transmission before being released. Speaker 2 questions if people were forced to get vaccinated to keep their jobs and asks Speaker 0 to retract their statement. Speaker 0 clarifies that everyone had the choice to get vaccinated or not, and they don't believe anyone was forced.

Speaker 0 questions if anyone was forced to get vaccinated, specifically referring to a comment made by Dr. Kuat. Speaker 1 confirms that they made the comment and states their belief that nobody was forced to receive the vaccine. They explain that mandates and requirements are determined by governments and health authorities, and that individuals were given the choice to get vaccinated or not. Speaker 0 disagrees, suggesting that many Australians would disagree with Speaker 1's statement.

The Pfizer COVID vaccine was not tested for its ability to stop the transmission of the virus before it entered the market. The speaker acknowledges that they had to work quickly to understand the situation and move at the speed of science.

Speaker 0 asks Speaker 1 to explain why the vaccine causes myocarditis and pericarditis. Speaker 1 mentions rare reports of myocarditis and pericarditis associated with vaccination but does not provide a clear explanation. Speaker 0 insists on understanding the mechanism and questions why the vaccine is considered safe without addressing the risks. Speaker 2 intervenes, suggesting that Speaker 1 will address the question later. Speaker 1 talks about the benefit-risk ratio and the global recommendation of health authorities. Speaker 0 reiterates the question, to which Speaker 1 agrees to provide a response later. Speaker 2 confirms this agreement.

Speaker 0 and Speaker 1 discuss vaccines and vaccine technology. Speaker 0 begins by saying, “He injected billions of people with an experimental it wasn't a bloody just no. It wasn't,” expressing that the vaccine was experimental and not straightforward. Speaker 1 counters briefly with, “It was no one isn't,” then suggests uncertainty about the claim. Speaker 0 adds that “Yes. It is. It's Well, it doesn't have a 100%,” indicating skepticism about a perfect success rate. Speaker 1 asks, “You think it's a definition of all point of is to give your body a,” challenging the stated purpose of the vaccine in terms of its aim to train the immune system. Speaker 0 then states, “protein train on. The immune system works. Technology,” implying that the vaccine trains the immune system and works as a technology. Speaker 1 responds that “Who cares if it's not the same? There's plenty there's,” implying there are multiple vaccines or approaches enough to matter, suggesting diversity in types. Speaker 0 replies, “different so types that they didn't have to contend with the fact that it wasn't the same technology.” Speaker 1 acknowledges that “There are different types of,” and that “There are different technologies. Fine. The mRNA is a type of vaccine.” Speaker 0 firmly rejects that, saying, “Now this is No. It was,” indicating a disagreement about the classification. Speaker 1 clarifies that “like this, and now it's like this,” implying a progression from one form to another. Speaker 0 insists, “No. No. No. It was like this, and now it's like this. The m n r mRNA technology was a radical, qualitative leap forward in technology.” He asserts that mRNA technology represents a significant advancement compared to what existed before. Speaker 1 suggests naming it differently or acknowledging changes, but Speaker 0 continues that “You can call it if you want to, but it bears very little resemblance to anything that went before that.” The final point is that “The reason it was called a scene was because was a brand name that had a track record of safety, and shoehorning it in that was one of the ways to make sure that people weren't terrified of the technology.”

Speaker 0 questions Speaker 1 about a report stating that serious adverse reactions occur in 1 in 800 vaccinated individuals. Speaker 1 claims to be unaware of the report but mentions routine screening of literature for adverse events. When asked about Moderna's rate of serious adverse events, Speaker 1 cannot provide the information. Speaker 0 expresses frustration and finds it extraordinary that a multinational company cannot provide this data. Speaker 1 offers to provide the information later but states that no safety concerns were observed in their clinical trials. Speaker 0 concludes that the conversation is a waste of time.

The speaker asked if the Pfizer COVID vaccine was tested for stopping virus transmission before it was released. They requested a clear yes or no answer and asked for the data to be shared with the committee. The speaker then stated that they did not have knowledge about stopping immunization before the vaccine entered the market.

Speaker 0 asked about the visibility of the medium to long-term effects of the vaccine in three to five years. Speaker 1 responded that they cannot predict how things will be in three to five years, but mentioned that 92-93% of the population will be vaccinated. Speaker 0 expressed confusion, and Speaker 1 clarified that 92-93% is the current vaccination rate. Speaker 0 raised concerns about potential side effects, but Speaker 1 reassured them that if there are any, the majority of the population would be affected. Speaker 0 remained unconvinced and expressed hesitation about getting vaccinated.

Speaker 0 questions whether it is a conflict of interest for government employees who profit from the vaccine to dictate vaccine policies. Speaker 1 responds that the government should decide. Speaker 0 asks about the higher incidence of myocarditis among adolescent males after vaccination. Speaker 1 claims that the data shows less risk with the vaccine compared to getting COVID. Speaker 0 disagrees and presents peer-reviewed papers contradicting Speaker 1's claim. Speaker 0 questions the scientific soundness of mandating three vaccines for adolescent boys and suggests having a rational discussion about one vaccine. Speaker 1 defers to public health leaders. Speaker 0 criticizes the CDC's recommendation to vaccinate children multiple times and compares it to other countries' approaches. Speaker 1 admits to vaccinating their own children multiple times. Speaker 0 argues that the risk of myocarditis after vaccination should be weighed against the risk of the disease. Speaker 0 also expresses concern about conflicts of interest in government decision-making.

The speaker asks Pfizer and Moderna to explain how the COVID-19 vaccine causes myocarditis. The response from the doctors is that the exact mechanism is still being studied, but myocarditis is generally an autoimmune response that can occur after COVID-19 or other infections. The speaker questions if other organs could also be affected by the vaccine, but the doctors explain that ongoing surveillance is in place to monitor potential risks. The speaker expresses concern about the lack of initial disclosure of these risks. The doctors emphasize the importance of preventing COVID-19 and state that the reported rate of myocarditis is around 2-3 per 100,000 doses. The speaker argues that if it can happen to the heart, it could happen to other organs. The conversation ends due to time constraints.

Speaker 0 asks Speaker 1 to explain the process of how the vaccine causes myocarditis and pericarditis. Speaker 1 mentions rare reports of myocarditis and pericarditis associated with vaccination. Speaker 0 insists on an explanation of the mechanism, but Speaker 1 does not provide a direct answer. Speaker 1 emphasizes that all medicines have benefits and side effects and refers to the benefit-risk ratio. Speaker 0 continues to press for an explanation of the biochemical pathway, but Speaker 1 agrees to provide a response later. The transcript ends with Speaker 2 confirming Speaker 1's agreement to give a further response.

Speaker 0 assures that reported side effects of the vaccine are expected and not concerning. They urge people to report any unusual reactions. Speaker 1 emphasizes the importance of transparency and unbiased investigation into outbreaks following vaccination. They question the accuracy of recording underlying causes of death related to COVID-19. Speaker 0 dismisses these concerns, stating that spreading doubts about vaccine safety during a pandemic is dangerous and undermines public health. Speaker 1 finds the minister's response concerning and ends the conversation.